Future Market Insights, Inc. (FMI) is an ESOMAR-certified, ISO 9001:2015 market research and consulting organization, trusted by Fortune 500 clients and global enterprises. With operations in the U.S.

Anzupgo (R) (delgocitinib cream) is currently approved in Canada, United States, European Union, United Kingdom, Switzerland and the United Arab Emirates under the brand name Anzupgo (R) for the ...

Eczema, or atopic dermatitis, is a chronic inflammatory skin disease that results in redness, itching, dryness, and ...

"After one week, I’ve tossed out creams from Beekman, F.A.B., and Biossance because this humble cream outperforms them all," ...

An international team of investigators has reported results from the first Phase III clinical trials of rocatinlimab, a novel ...

From red carpet events to carpool selfies and everything in between, Tori Spelling and her family live in the spotlight. As ...

Actress Tori Spelling and board certified dermatologist Dr. Adam Friedman are helping raise awareness of Eczema and encourage those who are struggling with it to reach ...

Network meta-analysis of five studies compares chronic hand eczema monotherapies, ranking ten treatments by HECSI score ...

Learn scabies symptoms, causes, and treatments. Spot early signs, know the risks, and discover effective ways to treat and ...

We hit the ice with history-making Olympic gold medalist Erin Jackson to talk eczema and EBGLYSS alongside Dr. Camille Howard ...

A BBC health expert has shared a promising update on a new drug that has been approved for the treatment of eczema, a debilitating skin condition, which will help more than 62,000 people in England.